Haorui Pharma-Chem Inc.

About Haorui Products Technology Contact
 
API Index
 
A
Adapalene
Alfuzosin HCl
  Altrenogest 
  Amifostine
  5-Aminolevulinic acid 
  Amisulpride
  Amlexanox
  Amorolfine HCl   
  Anastrozole 
  Ascomycin (FK520)
  Atracurium besylate
  Azelastine HCl
  Aztreonam
  B
  Benidipine HCl 
  Bicalutamide
  Brimonidine tartrate
  C
  Camptothecin
  Candesartan cilexetil 
  Capecitabine
  D
  Daptomycin
  Dasatinib
  Desogestrel
  Dexrazoxane 
  Dirithromycin
  Dipeptiven
  Docetaxel
  Dofetilide
  Dolasetron mesylate
  Donepezil HCl
  Doramectin
  Doxazosin mesylate
  Drospirenone
  E
  Entecavir
  Epalrestat
  Eplerenone
  Epinastine HCl
  Eplerenone
  Erlotinib HCl
  Erythromycin ethylsuccinate
  Escitalopram oxalate
  Estradiol
  Estradiol Benzoate
  Estriol
  Ethinyl Estradiol
  Everolimus
  Exemestane
  Everolimus
  F
  Fipronil
  Fludarabine phosphate
  Flumazenil
  Fluvastatin sodium
  G
  Gefitinib
  Gemcitabine HCl
  Gestodene
  Gestrinone
  Glimepiride
  Granisetron HCl
  H
  10-hydroxycamptothecin
  I
  Ibandronate sodium
  Ibutilide fumarate
  Imatinib mesylate
  Imipenem + Cilastatin sodium 
  Irbesartan 
  Irinotecan HCl 
  L
  Latanoprost
  Lenalidomide
  Letrozole
  Levetiracetam
  Levofloxacin 
  Levonorgestrel 
  Linezolid
  Lymecycline
  Lynoestrenol 
  M
  Maraviroc
  Melengestrol acetate
  Memantine HCl   
  Meropenem  
  Mestranol
  Methazolamide
  Mifepristone 
  Midazolam
  Miglitol 
  Mitoxantrone HCl
  Mizolastine HCl 
  Mofegiline HCl
  Mosapride citrate
  Moxidectin
  Mupirocin
  N
  N(2)-L-alanyl-L-glutamine
  Nandrolone phenylpropionate
  Nabumetone
  Natamycin
  Nebivolol
  Nedaplatin
  Nilutamide
  Norelgestromin 
  Norgestimate
  O
  Olanzapine
  Orlistat 
  Oxaliplatin 
  P
  Paclitaxel
  Palonosetron
  Pamidronate Disodium
  Pemetrexed Disodium
  Pemirolast potassium
  Polymyxin B sulfate
  Pramipexole 2HCl 
  Pranlukast hydrate
  R
  Racecadotril
  Rilmenidine
  Ramosetron
  Ranolazine
  Rapamycin (Sirolimus) 
  Rebamipide 
  Retigabine
  Rifaximine
  Rilmenidine  
  Riluzole 
  Risedronate sodium
  Rizatriptan benzoate
  Ropinirole
  Ropivacaine HCL
  S
  Sirolimus (Rapamycin) 
  Sorafenib Tosylate
  Sunitinib Malate
  T
  Tacrolimus (FK506) 
  Tamsulosin HCl 
  Tazobactam+Piperacillin 
  Teicoplanin
  Telmisartan 
  Temozolomide 
  Terazosin HCl
  Tibolone
  Tigecycline
  Topotecan HCl
  Travoprost
  Trenbolone Acetate
  Trimegestone
  Tropisetron HCL
  V
  Valsartan 
  Valrubicin 
  Vancomycin HCl
  Vecuronium bromide
  Venlafaxine HCl   
  Vinorelbine tartrate
  Voglibose
  Voriconazole
  Z
  Zanamivir
  Zoledronic acid
  Zolmitriptan
  Zonisamide

 

Haorui supplies  Amisulpride API (Active Pharmaceutical Ingredient) to pharmaceutical industry, our  Amisulpride API  API is produced by FDA approved cGMP facility.  Haorui supply APIs from small R&D to large commercial quantity, for product and supply detail please contact us. 
Amisulpride Clinical Trials
1   Completed   SOLIACS: Solian Solution in the Acute Setting
Condition:   Schizophrenia
Intervention:   Drug: amisulpride
 
2   Completed   Amisulpride in Schizophrenic Patients
Condition:   Schizophrenia
Intervention:   Drug: Amisulpride
 
3   Completed   SOLMANIA - Comparison of Valproate-Amisulpride and Valproate-Haloperidol in Bipolar I Patients
Condition:   Bipolar Disorder
Intervention:   Drug: Amisulpride
 
4   Completed   ASAP - Amisulpride in Schizophrenic Acute Phase Patients
Condition:   Schizophrenia
Intervention:   Drug: AMISULPRIDE
 
5   Recruiting   Modulation of Regional Brain Activation in Schizophrenic Patients by Pharmacological Therapy
Condition:   Schizophrenia
Interventions:   Drug: Amisulpride;   Drug: Olanzapine;   Drug: Haloperidol
 
6   Not yet recruiting   Benzamide Derivates as Treatment of Clozapine-Induced Hypersalivation
Condition:   Clozapine-Induced Hypersalivation
Intervention:   Drug: Amisulpride, Tiapride, Moclobemide
 
7   Active, not recruiting   Early Pharmacological and Psychological Intervention for Late Prodromal States of Psychosis
Conditions:   Schizophrenia;   Psychoses
Interventions:   Behavioral: Clinical Management (CM);   Drug: Amisulpride
 
8   Completed   Evaluation of the Antipsychotic Efficacy of Cannabidiol in Acute Schizophrenic Psychosis
Condition:   Schizophrenia
Interventions:   Drug: Cannabidiol;   Drug: Amisulpride
 
9   Recruiting   Characterize The Modulatory Effects Of Dopamine D2/D3 Receptor Agonist And Antagonist Drugs On Compulsive Behaviors
Condition:   Obsessive-Compulsive Disorder
Intervention:   Drug: Pramipexole, Amisulpride
 
10   Active, not recruiting   SWitching to Abilify Trial (SWAT)
Condition:   Schizophrenia
Intervention:   Drug: Aripiprazole, Solian, Olanzapine, Seroquel, Risperidone

 

 
 
 
 

Haorui - Your Partner to Pharmaceutical Success - Copy Right Reserved